Search results for: 'c-Abl'
-
A5467 Ponatinib (AP24534)1 CitationTarget: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
-
A2942 Masitinib (AB1010)Target: PDGFR|c-Kit|LynSummary: Tyrosine kinase inhibitor, potent and selective
-
A8236 Regorafenib4 CitationTarget: Raf|VEGFR|PDGFR|c-Kit|RETSummary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
-
B2171 Imatinib (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Protein-tyrosine kinase inhibitor
-
B5846 Radotinib(IY-5511)Target: PDGFR|Bcr-AblSummary: Bcr-Abl tyrosine kinase inhibitor
-
A8476 MK-2461Target: FLT3|PDGFR|MET|RonSummary: C-Met (WT/mutants) inhibitor
-
A8370 Axitinib (AG 013736)1 CitationTarget: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit inhibitor
-
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
-
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: Dual inhibitor of tyrosine and phosphoinositide kinases
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor